Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.91 USD
Change Today -0.0049 / -0.54%
Volume 22.9K
COCP On Other Exchanges
As of 9:59 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

cocrystal pharma inc (COCP) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/31/15 - $1.53
52 Week Low
08/5/14 - $0.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for COCRYSTAL PHARMA INC (COCP)

Related News

No related news articles were found.

cocrystal pharma inc (COCP) Related Businessweek News

No Related Businessweek News Found

cocrystal pharma inc (COCP) Details

Cocrystal Pharma, Inc., a preclinical-stage biopharmaceutical company, intends to develop medicines for use in treating human viral diseases. The company focuses on developing inhibitors that viral replication enzymes and viral replication protein. It is developing antiviral therapeutics for human diseases, including Hepatitis C virus, Influenza virus, and Norovirus. The company also develops targeted in-house chemical libraries consisting of antiviral compounds of nucleosides, non-nucleoside inhibitors, metal-binding inhibitors, and fragments. In addition, it is developing compounds that inhibit HCV helicase, an enzyme that is essential for hepatitis C viral replication. The company was founded in 2007 and is headquartered in Bothell, Washington.

22 Employees
Last Reported Date: 03/31/15
Founded in 2007

cocrystal pharma inc (COCP) Top Compensated Officers

Co-Founder and President
Total Annual Compensation: $180.0K
Co-Founder, Vice Chairman, Senior Advisor and...
Total Annual Compensation: $250.0K
Chief Financial Officer , Principal Accountin...
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2014.

cocrystal pharma inc (COCP) Key Developments

Cocrystal Pharma, Inc. Names Walt Addison Linscott, Esq. as General Counsel and Corporate Secretary

Cocrystal Pharma, Inc. announced the appointment of Walt Addison Linscott, Esq. as General Counsel and Corporate Secretary. Most recently, Linscott served as Global Strategic Legal Advisor for Thompson Hine, LLP. Linscott's experience as a lawyer spans 25 years and includes serving as General Counsel and Corporate Secretary of Carestream Health, Inc., leading as Chair of the Life Sciences practice and office managing partner of an international law firm and serving as the Vice President, General Counsel and Corporate Secretary of a branded pharmaceutical company that was sold to Abbott Laboratories.

Cocrystal Pharma, Inc. Proposes Amendments to Certificate of Incorporation

Cocrystal Pharma, Inc. at the annual meeting of the shareholders to be held on June 29, 2015, proposed amendments to Certificate of Incorporation to effect any of three reverse stock splits.

Cocrystal Pharma, Inc., Annual General Meeting, Jun 29, 2015

Cocrystal Pharma, Inc., Annual General Meeting, Jun 29, 2015., at 13:00 US Eastern Standard Time. Location: 1860 Montreal Road. Agenda: To elect members to Board of Directors; to approve and ratify the 2015 equity incentive plan; to approve an amendment to Certificate of Incorporation to effect any of three reverse stock splits; to approve Cocrystal’s named executive officer compensation; to vote, on a non-binding advisory basis, whether a non-binding advisory vote on Cocrystal’s executive compensation should be held every one, two or three years; to ratify the appointment of independent registered public accounting firm for fiscal year 2015; and for the transaction of such other matters as may properly come before the Annual Meeting.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COCP:US $0.91 USD -0.0049

COCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for COCP.
View Industry Companies

Industry Analysis


Industry Average

Valuation COCP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 11,118.3x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17,095.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COCRYSTAL PHARMA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at